WAY-383487

CAS No. 748146-89-6

WAY-383487( —— )

Catalog No. M28817 CAS No. 748146-89-6

WAY-383487 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 110 In Stock
5MG 116 In Stock
10MG 187 In Stock
25MG 316 In Stock
50MG 462 In Stock
100MG 644 In Stock
200MG Get Quote In Stock
500MG 1349 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-383487
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-383487 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
  • Description
    WAY-383487 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    Microtubule Associated
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    748146-89-6
  • Formula Weight
    293.338
  • Molecular Formula
    C16H20FNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CC1(CC(=O)Nc2ccc(F)cc2)CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kwon A, et al. Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer. Biomedicines. 2020 Sep 9;8(9):338.
molnova catalog
related products
  • Atevirdine

    Atevirdine is an HIV-1 reverse transcriptase inhibitor with antiviral activity for the study of the AIDS dementia complex (ADC).

  • PF-4776548

    PF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.

  • ST7612AA1

    ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo.